Clinical Trial Update: Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating two dosing regimens of duloxetine and amitriptyline for interstitial lung disease-related cough is currently recruiting at May…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Drugs mentioned

• Duloxetine (DULOXETINE)
• amitriptyline (amitriptyline)

Snippet

Sponsor: Mayo Clinic | Conditions: Interstitial Lung Disease | Phase 2 | Status: RECRUITING